User:Dileep D. Monie: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
mNo edit summary |
m (→Contact Info) |
||
| Line 5: | Line 5: | ||
*Dileep Monie | *Dileep Monie | ||
* | *[http://scholar.harvard.edu/dmonie Teaching Fellow, Harvard University] | ||
* | *[https://www.broadinstitute.org/directory/?usersearch=Dileep+Monie&usearch=Search Associated Researcher, Broad Institute of MIT and Harvard] | ||
*[[BUGSS|Director & Secretary, Baltimore Under Ground Science Space]] | |||
*[http://www.linkedin.com/in/dmonie Connect with me on LinkedIn] | *[http://www.linkedin.com/in/dmonie Connect with me on LinkedIn] | ||
*[[Special:Emailuser/Dileep D. Monie|Email me through OpenWetWare]] | *[[Special:Emailuser/Dileep D. Monie|Email me through OpenWetWare]] | ||
| Line 29: | Line 30: | ||
## Countermeasures - Designing fail-safe mechanisms to mitigate potential synthetic biology abuses | ## Countermeasures - Designing fail-safe mechanisms to mitigate potential synthetic biology abuses | ||
--> | --> | ||
==BBF Contributions== | ==BBF Contributions== | ||
*[[The_BioBricks_Foundation:Standards/Technical|Technical Standards]] | *[[The_BioBricks_Foundation:Standards/Technical|Technical Standards]] | ||
Revision as of 14:29, 29 September 2015
Contact Info
- Dileep Monie
- Teaching Fellow, Harvard University
- Associated Researcher, Broad Institute of MIT and Harvard
- Director & Secretary, Baltimore Under Ground Science Space
- Connect with me on LinkedIn
- Email me through OpenWetWare
I learned about OpenWetWare from the 24C3 Endy lecture, and I've joined because I am interested in making biology easier to engineer.
BBF Contributions
OWW Brain Dump
Publications
- Monday SR, Vath GM, Ferens WA, Deobald C, Rago JV, Gahr PJ, Monie DD, Iandolo JJ, Chapes SK, Davis WC, Ohlendorf DH, Schlievert PM, and Bohach GA. Unique superantigen activity of staphylococcal exfoliative toxins. J Immunol. 1999 Apr 15;162(8):4550-9.
- Vath GM, Earhart CA, Monie DD, Iandolo JJ, Schlievert PM, and Ohlendorf DH. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry. 1999 Aug 10;38(32):10239-46. DOI:10.1021/bi990721e |
- Kelly JR, Rubin AJ, Davis JH, Ajo-Franklin CM, Cumbers J, Czar MJ, de Mora K, Glieberman AL, Monie DD, and Endy D. Measuring the activity of BioBrick promoters using an in vivo reference standard. J Biol Eng. 2009 Mar 20;3:4. DOI:10.1186/1754-1611-3-4 |
- Oh U, McCormick MJ, Datta D, Turner RV, Bobb K, Monie DD, Sliskovic DR, Tanaka Y, Zhang J, Meshulam J, and Jacobson S. Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. Blood. 2011 Mar 24;117(12):3363-9. DOI:10.1182/blood-2010-10-306571 |
- ISBN:9780781764964
Contributed section on "Pulmonary Hypertension" (pp. 148-9)
